APO RESEARCH · REPORT
Prostacyclin
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
Product & engineering
Understand the product.
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
Selected research
Industry Research
Prostacyclin Industry Research Report 2026
Market perspective
Prostaglandins are autocank derived from arachidonic acid. They both sustain homeostatic functions and mediate pathogenic mechanisms, including the inflammatory response. Prostaglandins control several processes in the body, especially as it relates to the healing process. When tissue is damaged or infected, this group of hormones will create the reactions that cause pain, fever and inflammation, which sparks the healing process. Prostaglandins also stimulate the formation of a blood clot and the contraction of the blood vessel wall when body is bleeding. Once blood clots are no longer needed and the injury begins to heal, another prostaglandin will stimulate the changes that allow the clots to dissipate and the blood vessel wall to relax.
United Therapeutics monopolizes the global Prostacyclin market, holding a share about 70%.
North America is the largest market, with a share about 80%, followed by Europe and Japan, have a share about 15 percent.
Read the full market overview
In terms of product, Beraprost Sodium is the largest segment, with a share over 50%. And in terms of application, the largest application is For Oral, followed by For Injection, For Inhalation.
Report Scope
This report quantifies the global Prostacyclin market in terms of revenue (US$ million) and, where applicable, sales volume (K Unit), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Unit) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prostacyclin Market by Company
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
Prostacyclin Segment by Type
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Prostacyclin Segment by Application
For Injection
For Oral
For Inhalation
Prostacyclin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostacyclin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prostacyclin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostacyclin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Prostacyclin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Prostacyclin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Prostacyclin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Epoprostenol Sodium
- Treprostinil
- Iloprost
- Beraprost Sodium
Applications
- For Injection
- For Oral
- For Inhalation
Companies covered
- United Therapeutics
- Actelion (J & J)
- GSK
- Teva
- Toray
- Tide Pharma
- Bayer AG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Prostacyclin Market Size (2021-2032)
- 2.2.2 Global Prostacyclin Sales (2021-2032)
- 2.2.3 Global Prostacyclin Market Average Price (2021-2032)
- 2.3 Prostacyclin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Epoprostenol Sodium
- 2.3.3 Treprostinil
- 2.3.4 Iloprost
- 2.3.5 Beraprost Sodium
- 2.4 Prostacyclin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 For Injection
- 2.4.3 For Oral
- 2.4.4 For Inhalation
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Prostacyclin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Prostacyclin Sales (K Unit) of Manufacturers (2021-2026)
- 3.3 Global Prostacyclin Revenue of Manufacturers (2021-2026)
- 3.4 Global Prostacyclin Average Price by Manufacturers (2021-2026)
- 3.5 Global Prostacyclin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Prostacyclin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Prostacyclin, Product Type & Application
- 3.8 Global Manufacturers of Prostacyclin, Established Date
- 3.9 Global Prostacyclin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 United Therapeutics
- 4.1.1 United Therapeutics Company Information
- 4.1.2 United Therapeutics Business Overview
- 4.1.3 United Therapeutics Prostacyclin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 United Therapeutics Prostacyclin Product Portfolio
- 4.1.5 United Therapeutics Recent Developments
- 4.2 Actelion (J & J)
- 4.2.1 Actelion (J & J) Company Information
- 4.2.2 Actelion (J & J) Business Overview
- 4.2.3 Actelion (J & J) Prostacyclin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Actelion (J & J) Prostacyclin Product Portfolio
- 4.2.5 Actelion (J & J) Recent Developments
- 4.3 GSK
- 4.3.1 GSK Company Information
- 4.3.2 GSK Business Overview
- 4.3.3 GSK Prostacyclin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GSK Prostacyclin Product Portfolio
- 4.3.5 GSK Recent Developments
- 4.4 Teva
- 4.4.1 Teva Company Information
- 4.4.2 Teva Business Overview
- 4.4.3 Teva Prostacyclin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teva Prostacyclin Product Portfolio
- 4.4.5 Teva Recent Developments
- 4.5 Toray
- 4.5.1 Toray Company Information
- 4.5.2 Toray Business Overview
- 4.5.3 Toray Prostacyclin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Toray Prostacyclin Product Portfolio
- 4.5.5 Toray Recent Developments
- 4.6 Tide Pharma
- 4.6.1 Tide Pharma Company Information
- 4.6.2 Tide Pharma Business Overview
- 4.6.3 Tide Pharma Prostacyclin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Tide Pharma Prostacyclin Product Portfolio
- 4.6.5 Tide Pharma Recent Developments
- 4.7 Bayer AG
- 4.7.1 Bayer AG Company Information
- 4.7.2 Bayer AG Business Overview
- 4.7.3 Bayer AG Prostacyclin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer AG Prostacyclin Product Portfolio
- 4.7.5 Bayer AG Recent Developments
5 Global Prostacyclin Market Scenario by Region
- 5.1 Global Prostacyclin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Prostacyclin Sales by Region: 2021-2032
- 5.2.1 Global Prostacyclin Sales by Region: 2021-2026
- 5.2.2 Global Prostacyclin Sales by Region: 2027-2032
- 5.3 Global Prostacyclin Revenue by Region: 2021-2032
- 5.3.1 Global Prostacyclin Revenue by Region: 2021-2026
- 5.3.2 Global Prostacyclin Revenue by Region: 2027-2032
- 5.4 North America Prostacyclin Market Facts & Figures by Country
- 5.4.1 North America Prostacyclin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Prostacyclin Sales by Country (2021-2032)
- 5.4.3 North America Prostacyclin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Prostacyclin Market Facts & Figures by Country
- 5.5.1 Europe Prostacyclin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Prostacyclin Sales by Country (2021-2032)
- 5.5.3 Europe Prostacyclin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Prostacyclin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Prostacyclin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Prostacyclin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Prostacyclin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Prostacyclin Market Facts & Figures by Country
- 5.7.1 South America Prostacyclin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Prostacyclin Sales by Country (2021-2032)
- 5.7.3 South America Prostacyclin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Prostacyclin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Prostacyclin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Prostacyclin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Prostacyclin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Prostacyclin Sales by Type (2021-2032)
- 6.1.1 Global Prostacyclin Sales by Type (2021-2032) & (K Unit)
- 6.1.2 Global Prostacyclin Sales Market Share by Type (2021-2032)
- 6.2 Global Prostacyclin Revenue by Type (2021-2032)
- 6.2.1 Global Prostacyclin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Prostacyclin Revenue Market Share by Type (2021-2032)
- 6.3 Global Prostacyclin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Prostacyclin Sales by Application (2021-2032)
- 7.1.1 Global Prostacyclin Sales by Application (2021-2032) & (K Unit)
- 7.1.2 Global Prostacyclin Sales Market Share by Application (2021-2032)
- 7.2 Global Prostacyclin Revenue by Application (2021-2032)
- 7.2.1 Global Prostacyclin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Prostacyclin Revenue Market Share by Application (2021-2032)
- 7.3 Global Prostacyclin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Prostacyclin Value Chain Analysis
- 8.1.1 Prostacyclin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Prostacyclin Production Mode & Process
- 8.2 Prostacyclin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Prostacyclin Distributors
- 8.2.3 Prostacyclin Customers
9 Global Prostacyclin Analyzing Market Dynamics
- 9.1 Prostacyclin Industry Trends
- 9.2 Prostacyclin Industry Drivers
- 9.3 Prostacyclin Industry Opportunities and Challenges
- 9.4 Prostacyclin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst